Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The influenza virus can cause seasonal infections with mild to severe symptoms, circulating worldwide, and it can affect people in any age group. Therefore, this infection is a serious public health problem that causes severe illness and death in high-risk populations. Every year, 0.5% of the world’s population is infected by this pathogen. This percentage can increase up to ten times during pandemics. Influenza vaccination is the most effective way to prevent disease. In addition, anti-influenza drugs are essential for prophylactic and therapeutic interventions. The oseltamivir (OST, a neuraminidase inhibitor) is the primary antiviral used in clinics during outbreaks. However, OST resistant viruses may emerge naturally or due to antiviral pressure, with a prevalence of 1–2% worldwide. Thus, the search for new anti-influenza drugs is extremely important. Currently, several groups have been developing studies describing the biotechnological potential of microalgae and cyanobacteria, including antiviral activity of their extracts. In Brazil, this potential is poorly known and explored. Methods: With the aim of increasing the knowledge on this topic, 38 extracts from microalgae and cyanobacteria isolated from marine and freshwater biomes in Brazil were tested against: cellular toxicity; OST-sensitive and resistant influenza replications; and neuraminidase activity. Results: For this purpose, Madin-Darby Canine Kidney (MDCK)-infected cells were treated with 200 μg/mL of each extract. A total of 17 extracts (45%) inhibited influenza A replication, with seven of them resulting in more than 80% inhibition. Moreover, functional assays performed with viral neuraminidase revealed two extracts (from Leptolyngbya sp. and Chlorellaceae) with IC 50 mean < 210 μg/mL for influenza A and B, and also OST-sensitive and resistant strains. Furthermore, MDCK cells exposed to 1 mg/mL of all the extracts showed viability higher than 80%. Discussion: Our results suggest that extracts of microalgae and cyanobacteria have promising anti-influenza properties. Further chemical investigation should be conducted to isolate the active compounds for the development of new anti-influenza drugs. The data generated contribute to the knowledge of the biotechnological potential of Brazilian biomes that are still little explored for this purpose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marine microalgae with anti-cancer properties
Martínez Andrade, K., Lauritano, C., Romano, G., & Ianora, A. (2018) · Marine Drugs · doi:10.3390/md16050165 · Cited by 284
Hasui, M., Matsuda, M., Okutani, K., & Shigeta, S. (1995) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(95)98157-t · Cited by 172 · cited 1×
“Marine and freshwater natural products have been reported to contain different biological activities, which allow them to provide health and cosmetic benefits, such as antioxidant, anti-inflammatory, anticancer and antiviral activity, including against some respiratory viruses (Chen et al., 2016; Hasui et al., 1995; K…”
BackgroundChen, Y.-H., Chang, G.-K., Kuo, S.-M., Huang, S.-Y., Hu, I.-C., Lo, Y.-L., & Shih, S.-R. (2016) · Scientific Reports · doi:10.1038/srep24253 · Cited by 112
Cited by
Potential utilization of bioproducts from microalgae for the quality enhancement of natural products
Tang, D. Y. Y., Khoo, K. S., Chew, K. W., Tao, Y., Ho, S.-H., & Show, P. L. (2020) · Bioresource Technology · doi:10.1016/j.biortech.2020.122997 · Cited by 390
Microalgal Cell Biofactory—Therapeutic, Nutraceutical and Functional Food Applications
Kiran, B. R., & Venkata Mohan, S. (2021) · Plants · doi:10.3390/plants10050836 · Cited by 124
“…(VSV), Encephalomyocarditis virus, Flu-A and Flu-B, respiratory syncytial virus types A (RSV-A) and B (RSV-B), measles, mumps Falaise et al., 2016 [101]; Huleihel et al., 2002 [114]; Raposo et al., 2014 [74]; Santoyo et al., 2011 [113]; Silva et al., 2018 [112]; Talyshinsky et al., 2002 [115] 4.”
Algae-derived bioactive molecules for the potential treatment of SARS-CoV-2
Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J. (2021) · Molecules · doi:10.3390/molecules26082134 · Cited by 69
Antiviral Cyanometabolites—A Review
Mazur-Marzec, H., Cegłowska, M., Konkel, R., & Pyrć, K. (2021) · Biomolecules · doi:10.3390/biom11030474 · Cited by 64
Advances in the Biotechnological Potential of Brazilian Marine Microalgae and Cyanobacteria
Oliveira, D. T. D., Costa, A. A. F. D., Costa, F. F., Rocha Filho, G. N. D., & Nascimento, L. A. S. D. (2020) · Molecules · doi:10.3390/molecules25122908 · Cited by 21
Metadata
- Authors
- Silva, T., S. Salomon, P., Hamerski, L., Walter, J., B. Menezes, R., Siqueira, J. E., Santos, A., Santos, J. A. M., Ferme, N., Guimarães, T., O. Fistarol, G., I. Hargreaves, P., Thompson, C., Thompson, F., Souza, T. M., Siqueira, M., & Miranda, M.
- Venue
- PeerJ
- Publisher
- PeerJ
- Published
- 2018-10-26
- Volume
- 6
- Pages
- e5716
- ISSN
- 2167-8359 (ISSN-L)
- OpenAlex
- W2898089106
- Cited by
- 46
- References
- 3
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity. https://app.cochat.ai/papers/10.7717/peerj.5716
- The paper
- Silva, T., S. Salomon, P., Hamerski, L., Walter, J., B. Menezes, R., Siqueira, J. E., Santos, A., Santos, J. A. M., Ferme, N., Guimarães, T., O. Fistarol, G., I. Hargreaves, P., Thompson, C., Thompson, F., Souza, T. M., Siqueira, M., & Miranda, M. (2018). Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity. PeerJ. https://doi.org/10.7717/peerj.5716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.